Quercetin as an inhibitor of snake venom secretory phospholipase A2

Cotrim C.A.; De Oliveira S.C.B.; Diz Filho E.B.S.; Fonseca F.V.; Baldissera Jr. L.; Antunes E.; Ximenes R.M.; Monteiro H.S.A.; Rabello M.M.; Hernandes M.Z.; De Oliveira Toyama D.; Toyama M.H.

Quercetin as an inhibitor of snake venom secretory phospholipase A2

Tipo

Artigo

Data de publicação

2011

Periódico

Chemico-Biological Interactions

Citações (Scopus)

63

Autores

Cotrim C.A.
De Oliveira S.C.B.
Diz Filho E.B.S.
Fonseca F.V.
Baldissera Jr. L.
Antunes E.
Ximenes R.M.
Monteiro H.S.A.
Rabello M.M.
Hernandes M.Z.
De Oliveira Toyama D.
Toyama M.H.

Resumo

As polyphenolic compounds isolated from plants extracts, flavonoids have been applied to various pharmaceutical uses in recent decades due to their anti-inflammatory, cancer preventive, and cardiovascular protective activities. In this study, we evaluated the effects of the flavonoid quercetin on Crotalus durissus terrificus secretory phospholipase A2 (sPLA2), an important protein involved in the release of arachidonic acid from phospholipid membranes. The protein was chemically modified by treatment with quercetin, which resulted in modifications in the secondary structure as evidenced through circular dichroism. In addition, quercetin was able to inhibit the enzymatic activity and some pharmacological activities of sPLA2, including its antibacterial activity, its ability to induce platelet aggregation, and its myotoxicity by approximately 40%, but was not able to reduce the inflammatory and neurotoxic activities of sPLA2. These results suggest the existence of two pharmacological sites in the protein, one that is correlated with the enzymatic site and another that is distinct from it. We also performed molecular docking to better understand the possible interactions between quercetin and sPLA2. Our docking data showed the existence of hydrogen-bonded, polar interactions and hydrophobic interactions, suggesting that other flavonoids with similar structures could bind to sPLA2. Further research is warranted to investigate the potential use of flavonoids as sPLA2 inhibitors. © 2010 Elsevier Ireland Ltd. All rights reserved.